Comparison of lipid profiles and attainment of lipid goals in patients <65 years versus patients ≥65 years (from the Lipid Treatment Assessment Project [L-TAP] 2)

American Journal of Cardiology

Volumn 109, Issue 12, 2012, Pages 1738-1742

  Rodriguez, Fatima ^a   Santos, Raul D ^b   Messig, Michael ^c   Tarasenko, Lisa ^c   Ferrières, Jean ^d   Jukema, J Wouter ^e   Chiang, Cheng Wen ^f   Waters, David D ^g   Foody, Joanne M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c PFIZER INC   (United States)

^d CHU RANGUEIL   (France)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f CATHAY GENERAL HOSPITAL   (Taiwan)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; STATIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ASIA; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DYSLIPIDEMIA; EUROPE; FAMILY HISTORY; FEMALE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NORTH AMERICA; PRIORITY JOURNAL; SMOKING; SOUTH AND CENTRAL AMERICA; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

AGE FACTORS; AGED; ASIA; CHOLESTEROL, HDL; DYSLIPIDEMIAS; EUROPE; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LATIN AMERICA; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; NORTH AMERICA; RISK FACTORS; TREATMENT OUTCOME;

EID: 84861613289     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.02.018     Document Type: Article

References (25)

1. D.D. Waters, C. Brotons, C.W. Chiang, J. Ferrières, J. Foody, J.W. Jukema, R.D. Santos, J. Verdejo, M. Messig, R. McPherson, K.B. Seung, L. Tarasenko Lipid Treatment Assessment Project 2 Investigators Lipid Treatment Assessment Project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals Circulation 120 2009 28 34
2. T.A. Pearson, I. Laurora, H. Chu, S. Kafonek The lipid Treatment Assessment Project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals Arch Intern Med 160 2000 459 467
3. S.M. Grundy, H.B. Brewer Jr, J.I. Cleeman, S.C. Smith Jr, C. Lenfant American Heart Association National Heart, Lung, and Blood Institute National Heart, Lung, and Blood Institute Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition Circulation 109 2004 433 438
4. National Cholesterol Education Program (NCEP) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 106 2002 3143 3421
5. A.T. Yan, R.T. Yan, M. Tan, D.G. Hackam, K.L. Leblanc, H. Kertland, J.L. Tsang, S. Jaffer, M.L. Kates, L.A. Leiter, D.H. Fitchett, A. Langer, S.G. Goodman Vascular Protection (VP) and Guidelines Oriented Approach to Lipid Lowering (GOALL) Registries Investigators Contemporary management of dyslipidemia in high-risk patients: targets still not met Am J Med 119 2006 676 683
6. J.S. Schultz, J.C. O'Donnell, K.L. McDonough, R. Sasane, J. Meyer Determinants of compliance with statin therapy and low-density lipoprotein cholesterol goal attainment in a managed care population Am J Manag Care 11 2005 306 312
7. D.M. Mann, J.P. Allegrante, S. Natarajan, E.A. Halm, M. Charlson Predictors of adherence to statins for primary prevention Cardiovasc Drugs Ther 21 2007 311 316
8. G. Chodick, V. Shalev, Y. Gerber, A.D. Heymann, H. Silber, V. Simah, E. Kokia Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel Clin Ther 30 2008 2167 2179
9. D.C. Chan, W.H. Shrank, D. Cutler, S. Jan, M.A. Fischer, J. Liu, J. Avorn, D. Solomon, M.A. Brookhart, N.K. Choudhry Patient, physician, and payment predictors of statin adherence Med Care 48 2010 196 202
10. V.L. Burt, P. Whelton, E.J. Roccella, C. Brown, J.A. Cutler, M. Higgins, M.J. Horan, D. Labarthe Prevalence of hypertension in the US adult population Results from the Third National Health and Nutrition Examination Survey, 1988-1991 Hypertension 25 1995 305 313
11. C.C. Cowie, K.F. Rust, D.D. Byrd-Holt, E.W. Gregg, E.S. Ford, L.S. Geiss, K.E. Bainbridge, J.E. Fradkin Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006 Diabetes Care 33 2010 562 568
12. M.L. Biggs, K.J. Mukamal, J.A. Luchsinger, J.H. Ix, M.R. Carnethon, A.B. Newman, I.H. de Boer, E.S. Strotmeyer, D. Mozaffarian, D.S. Siscovick Association between adiposity in midlife and older age and risk of diabetes in older adults JAMA 303 2010 2504 2512
13. W.Y. Craig, G.E. Palomaki, J.E. Haddow Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data BMJ 298 1989 784 788
14. P. Barter, A.M. Gotto, J.C. LaRosa, J. Maroni, M. Szarek, S.M. Grundy, J.J. Kastelein, V. Bittner, J.C. Fruchart Treating to New Targets Investigators HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events N Engl J Med 357 2007 1301 1310
15. C.J. Newschaffer, T.L. Bush, W.E. Hale Aging and total cholesterol levels: cohort, period, and survivorship effects Am J Epidemiol 136 1992 23 34
16. A. Ferrara, E. Barrett-Connor, J. Shan Total, LDL, and HDL cholesterol decrease with age in older men and women The Rancho Bernardo Study 1984-1994 Circulation 96 1997 37 43
17. H.M. Krumholz, T.E. Seeman, S.S. Merrill, C.F. Mendes de Leon, V. Vaccarino, D.I. Silverman, R. Tsukahara, A.M. Ostfeld, L.F. Berkman Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years JAMA 272 1994 1335 1340
18. A.W. Weverling-Rijnsburger, G.J. Blauw, A.M. Lagaay, D.L. Knook, A.E. Meinders, R.G. Westendorp Total cholesterol and risk of mortality in the oldest old Lancet 350 1997 1119 1123
19. S. Brescianini, S. Maggi, G. Farchi, S. Mariotti, A. Di Carlo, M. Baldereschi, D. Inzitari ILSA Group Low total cholesterol and increased risk of dying: are low levels clinical warning signs in the elderly? Results from the Italian Longitudinal Study on Aging J Am Geriatr Soc 51 2003 991 996
20. N. Schupf, R. Costa, J. Luchsinger, M.X. Tang, J.H. Lee, R. Mayeux Relationship between plasma lipids and all-cause mortality in nondemented elderly J Am Geriatr Soc 53 2005 219 226
21. C. Baigent, A. Keech, P.M. Kearney, L. Blackwell, G. Buck, C. Pollicino, A. Kirby, T. Sourjina, R. Peto, R. Collins, R. Simes Cholesterol Treatment Trialists (CTT) Collaborators Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins Lancet 366 2005 1267 1278
22. J.J. Brugts, T. Yetgin, S.E. Hoeks, A.M. Gotto, J. Shepherd, R.G. Westendorp, A.J. de Craen, R.H. Knopp, H. Nakamura, P. Ridker, R. van Domburg, J.W. Deckers The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials BMJ 338 2009 b2376
23. Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial Lancet 360 2002 7 22
24. D.T. Ko, M. Mamdani, D.A. Alter Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox JAMA 291 2004 1864 1870
25. G.A. Nichols, S. Nag, W. Chan Intensity of lipid-lowering therapy and low-density lipoprotein cholesterol goal attainment among the elderly before and after the 2004 National Cholesterol Education Program Adult Treatment Panel III update Am Heart J 154 2007 554 560